Market Cap

Verici Dx plc Market Capitalization:

£11.0 Million

GBP as of Jan. 1, 2026

US$14.8 Million

business Verici Dx plc Company Profile

Verici Dx plc Main Stock Listing

LSE: VRCI

Market Capitalization History of Verici Dx plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Verici Dx plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 £11.0 M 7.08%
Jan. 1, 2025 £10.2 M -53.75%
Jan. 1, 2024 £22.2 M -17.39%
Jan. 1, 2023 £26.8 M -75.53%
Jan. 1, 2022 £109.6 M -39.35%
Jan. 1, 2021 £180.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Verici Dx plc Categories

United Kingdom languages Healthcare languages Diagnostics & Research
United Kingdom Healthcare United Kingdom Diagnostics & Research

Stocks & Indices

Verici Dx plc has the following listings and related stock indices.


Stock: LSE: VRCI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.